Expression of proliferation markers and cell cycle regulators in T cell lymphoproliferative skin disorders

Journal of Dermatological Science

Volumn 49, Issue 2, 2008, Pages 125-132

  Gambichler, Thilo ^a   Bischoff, Stefan ^a   Bechara, Falk G ^a   Altmeyer, Peter ^a   Kreuter, Alexander ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Cell cycle; Cutaneous T cell lymphoma; Immunohistochemistry; Lymphoma; Proliferation

Indexed keywords

CYCLINE; KI 67 ANTIGEN; MINICHROMOSOME MAINTENANCE PROTEIN 7; PROTEIN P21;

ARTICLE; CANCER STAGING; CELL CYCLE REGULATION; CELL POPULATION; CELL PROLIFERATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOMATOID PAPULOSIS; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MYCOSIS FUNGOIDES; PARAPSORIASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE;

CELL CYCLE PROTEINS; CELL DIFFERENTIATION; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA-BINDING PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; LYMPHOMATOID PAPULOSIS; MYCOSIS FUNGOIDES; NEOPLASM STAGING; NUCLEAR PROTEINS; PARAPSORIASIS; PROGNOSIS; PROLIFERATING CELL NUCLEAR ANTIGEN; SKIN; SKIN NEOPLASMS; T-LYMPHOCYTE SUBSETS;

EID: 37349106061     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2007.07.011     Document Type: Article

References (33)

1. Quinn C.M., and Wright N.A. The clinical assessment of proliferation and growth in human tumours: evaluation of methods and applications as prognostic variables. J Pathol 160 (1990) 93-102
2. Toschi L., and Bravo R. Changes in cyclin/proliferating cell nuclear antigen distribution during DNA repair synthesis. J Cell Biol 107 (1988) 1623-1628
3. Ha S.A., Shin S.M., Namkoong H., Lee H., Cho G.W., Hur S.Y., et al. Cancer-associated expression of minichromosome maintenance 3 gene in several human cancers and its involvement in tumorigenesis. Clin Cancer Res 10 (2004) 8386-8395
4. Serrano M. The INK4a/ARF locus in murine tumorigenesis. Carcinogenesis 21 (2000) 865-869
5. Gartel A.L., and Radhakrishnan S.K. Lost in transcription: p21 repression, mechanisms, and consequences. Cancer Res 65 (2005) 3980-3985
6. Tachibana K.E., Gonzalez M.A., and Coleman N. Cell-cycle-dependent regulation of DNA replication and its relevance to cancer pathology. J Pathol 205 (2005) 123-129
7. Freeman A., Morris L.S., Mills A.D., Stoeber K., Laskey R.A., Williams G.H., et al. Minichromosome maintenance proteins as biological markers of dysplasia and malignancy. Clin Cancer Res 5 (1999) 2121-2132
8. Schrader C., Janssen D., Klapper W., Siebmann J.U., Meusers P., Brittinger G., et al. Minichromosome maintenance protein 6, a proliferation marker superior to Ki-67 and independent predictor of survival in patients with mantle cell lymphoma. Br J Cancer 93 (2005) 939-945
9. Padmanabhan V., Callas P., Philips G., Trainer T.D., and Beatty B.G. DNA replication regulation protein Mcm7 as a marker of proliferation in prostate cancer. J Clin Pathol 57 (2004) 1057-1062
10. Scholzen T., and Gerdes J. The Ki-67 protein: from the known and the unknown. J Cell Physiol 182 (2000) 311-322
11. Brown D.C., and Gatter K.C. Ki67 protein: the immaculate deception?. Histopathology 40 (2002) 2-11
12. Navas I.C., Ortiz-Romero P.L., Villuendas R., Martinez P., Garcia C., Gomez E., et al. p16(INK4a) gene alterations are frequent in lesions of mycosis fungoides. Am J Pathol 156 (2000) 1565-1572
13. Scarisbrick J.J., Woolford A.J., Calonje E., Photiou A., Ferreira S., Orchard G., et al. Frequent abnormalities of the p15 and p16 genes in mycosis fungoides and sezary syndrome. J Invest Dermatol 118 (2002) 493-499
14. Nagasawa T., Zhang Q., Raghunath P.N., Wong H.Y., El-Salem M., Szallasi A., et al. Multi-gene epigenetic silencing of tumor suppressor genes in T-cell lymphoma cells; delayed expression of the p16 protein upon reversal of the silencing. Leuk Res 30 (2006) 303-312
15. Tosca A., Linardopoulos S., Malliri A., Hatziolou E., Nicolaidou A., and Spandidos D.A. Implication of the ras and myc oncoproteins in the pathogenesis of mycosis fungoides. Anticancer Res 11 (1991) 1433-1438
16. Macaluso M., Montanari M., Cinti C., and Giordano A. Modulation of cell cycle components by epigenetic and genetic events. Semin Oncol 32 (2005) 452-457
17. Smoller B.R. The role of immunohistochemistry in the diagnosis of cutaneous lymphoma. Adv Dermatol 13 (1997) 207-234
18. Muskhelishvili L., Latendresse J.R., Kodell R.L., and Henderson E.B. Evaluation of cell proliferation in rat tissues with BrdU, PCNA, Ki-67 (MIB-5) immunohistochemistry and in situ hybridization for histone mRNA. J Histochem Cytochem 51 (2003) 1681-1688
19. Kanavaros P., Ioannidou D., Tzardi M., Datseris G., Katsantonis J., Delidis G., et al. Mycosis fungoides: expression of C-myc p62 p53, bcl-2 and PCNA proteins and absence of association with Epstein-Barr virus. Pathol Res Pract 190 (1994) 767-774
20. Clarke A.M.T., Reid W.A., and Jack A.S. Combined proliferating cell nuclear antigen and morphometric analysis in the diagnosis of cutaneous lymphoid infiltrates. J Clin Pathol 46 (1993) 129-134
21. Willemze R., Jaffe E.S., Burg G., Cerroni L., Berti E., Swerdlow S.H., et al. WHO-EORTC classification for cutaneous lymphomas. Blood 105 (2005) 3768-3785
22. Demierre M.F., Foss F.M., and Koh H. Proceedings of the international consensus conference on cutaneous T-cell lymphoma (CTCL) treatment recommendations. J Am Acad Dermatol 36 (1997) 460-466
23. Burg G., Dummer R., Nestle F.O., Doebbeling U., and Haeffner A. Cutaneous lymphomas consist of a spectrum of nosologically different entities including mycosis fungoides and small plaque parapsoriasis. Arch Dermatol 132 (1996) 567-572
24. Burg G., and Dummer R. Small plaque (digitate) parapsoriasis is an 'abortive cutaneous T-cell lymphoma' and is not mycosis fungoides. Arch Dermatol 131 (1995) 336-338
25. Breuckmann F., Freitag M., Rotterdam S., Stuecker M., Altmeyer P., and Kreuter A. Immunohistochemical investigations and introduction of new therapeutic strategies in scleromyxoedema: case report. BMC Dermatol 4 (2004) 12
26. Kempf W., Dummer R., and Burg G. Approach to lymphoproliferative infiltrates of the skin. The difficult lesions. Am J Clin Pathol 111 Suppl. 1 (1999) S84-S93
27. Assaf C., Hirsch B., Wagner F., Lucka L., Grunbaum M., Gellrich S., et al. Differential expression of TRAF1 aids in the distinction of cutaneous CD30-positive lymphoproliferations. J Invest Dermatol (2007) [Epub ahead of print]
28. Florell S.R., Cessna M., Lundell R.B., Boucher K.M., Bowen G.M., Harris R.M., et al. Usefulness (or lack thereof) of immunophenotyping in atypical cutaneous T-cell infiltrates. Am J Clin Pathol 125 (2006) 727-736
29. Wood G.S., Strickler J.G., Deneau D.G., Egbert B., and Warnke R.A. Lymphomatoid papulosis expresses immunophenotypes associated with T cell lymphoma but not inflammation. J Am Acad Dermatol 15 (1986) 444-458
30. Kikuchi A., and Nishikawa T. Apoptotic and proliferating cells in cutaneous lymphoproliferative diseases. Arch Dermatol 133 (1997) 829-833
31. Dummer R., Michie S.A., Kell D., Gould J.W., Haeffner A.C., Smoller B.R., et al. Expression of bcl-2 protein and Ki-67 nuclear proliferation antigen in benign and malignant cutaneous T-cell infiltrates. J Cutan Pathol 22 (1995) 11-17
32. Neish C., Charlry M., Jegasothy B., Tharp M., and Deng J.S. Proliferation cell nuclear antigen and soluble interleukin 2 receptor levels in cutaneous T cell lymphoma: correlation with advanced clinical diseases. J Dermatol Sci 8 (1994) 11-17
33. Stoeber K., Tlsty T.D., Happerfield L., Thomas G.A., Romanov S., Bobrow L., et al. DNA replication licensing and human cell proliferation. J Cell Sci 114 (2001) 2027-2041